Novavax Announces Agreement with Government of New Zealand for 10.7 Million Doses of COVID-19 Vaccine

Advance purchase agreement signed for NVX-CoV2373, Novavax’ adjuvanted protein vaccine candidate Advance purchase agreement signed for NVX-CoV2373, Novavax’ adjuvanted protein vaccine candidate

Original post:
Novavax Announces Agreement with Government of New Zealand for 10.7 Million Doses of COVID-19 Vaccine

Related Post